日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diabetes Fact Sheet 2025: Special Edition on Diabetes with Obesity and in Pregnancy

2025年糖尿病概况介绍:肥胖和妊娠期糖尿病特刊

Park, Se Eun; Min, Se Hee; Kim, Jin Hwa; Lee, Seung-Hwan; Jung, Han Na; Moon, Joon Ho; Han, Kyungdo; Ko, Seung-Hyun; Cha, Bong Soo; Choi, Sung Hee

Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial

在2型糖尿病患者中,洛贝格列酮作为恩格列净联合二甲双胍治疗的附加疗法可改善血糖控制:一项双盲、随机、安慰剂对照试验

Seo, Da Hea; Min, Kyung Wan; Sohn, Ho Sang; Kim, Sang Yong; Jeong, In-Kyung; Park, Cheol-Young; Yoon, Kun-Ho; Kim, So Hun; Cha, Bong-Soo

Diabetes Fact Sheet 2025: Comparative Epidemiology and Clinical Features of Obese and Non-Obese Diabetes in Korea

2025年糖尿病概况介绍:韩国肥胖与非肥胖糖尿病的流行病学和临床特征比较

Kim, Jin Hwa; Kim, Bongseong; Park, Se Eun; Ko, Seung-Hyun; Choi, Sung Hee; Cha, Bong Soo; Han, Kyungdo; Lee, Seung-Hwan

Diabetes Fact Sheets in Korea 2024

韩国糖尿病概况介绍(2024 年)

Park, Se Eun; Ko, Seung-Hyun; Kim, Ji Yoon; Kim, Kyuho; Moon, Joon Ho; Kim, Nam Hoon; Han, Kyung Do; Choi, Sung Hee; Cha, Bong Soo

Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP)

评估依那格列净对 2 型糖尿病患者心肾结局的随机对照试验的研究设计和方案 (ENVELOP)

Kim, Nam Hoon; Lim, Soo; Jeong, In-Kyung; Rhee, Eun-Jung; Moon, Jun Sung; Ryu, Ohk-Hyun; Kwon, Hyuk-Sang; Won, Jong Chul; Kim, Sang Soo; Kim, Sang Yong; Ku, Bon Jeong; Jin, Heung Yong; Kim, Sin Gon; Cha, Bong-Soo

Defining Severe Diabetes Mellitus: A Consensus Framework for Grading and Staging Diabetes Based on Pathophysiology and Complications

严重糖尿病的定义:基于病理生理学和并发症的糖尿病分级和分期共识框架

Bae, Jae Hyun; Choe, Hun Jee; Yang, Ye Seul; Seo, Mi Hae; Choi, Jong Han; Kim, Gyuri; Lyu, Young Sang; Han, Jeung Hun; Kang, Shinae; Kim, Won Jun; Kim, Kyung-Soo; Cho, Young Min; Cha, Bong Soo

Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes

弥合证据与实践的鸿沟:韩国糖尿病协会关于糖尿病筛查、药物治疗和重症糖尿病的共识声明

Choi, Jong Han; Kang, Shinae; Kim, Soo-Kyung; Kim, Won Jun; Kim, Ji Min; Bae, Jaehyun; Yun, Jae-Seung; Jeon, Eonju; Kim, Young-Eun; Bae, Jae Hyun; Choe, Hun Jee; Cho, Young Min; Ko, Seung-Hyun; Kim, Sang Yong; Kim, Hae Jin; Hwang, You-Cheol; Moon, Min Kyong; Chon, Suk; Kang, Seon Mee; Kwon, Hyuk-Sang; Kim, Mi Kyung; Lee, You-Bin; Min, Se Hee; Park, Jung Hwan; Lee, Woo Je; Cha, Bong-Soo; Lee, Byung-Wan

2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

2025年韩国糖尿病管理临床实践指南:韩国糖尿病协会的建议

Kang, Shinae; Kang, Seon Mee; Choi, Jong Han; Ko, Seung-Hyun; Koo, Bo Kyung; Kwon, Hyuk-Sang; Kim, Mi Kyung; Kim, Sang Yong; Kim, Soo-Kyung; Kim, Young-Eun; Kim, Eun Sook; Kim, Jae Hyeon; Kim, Chong Hwa; Kim, Ji Min; Kim, Hae Jin; Moon, Min Kyong; Moon, Sun Joon; Moon, Jun Sung; Moon, Joon Ho; Min, Se Hee; Park, Jung Hwan; Bae, Jaehyun; Song, Keeho; Ahn, Ji Yoon; Yun, Jae-Seung; Lee, Woo Je; Lee, You-Bin; Chon, Suk; Jeon, Eonju; Jin, Sang-Man; Han, Eugene; Hwang, You-Cheol; Bae, Jae Hyun; Song, YoonJu; Lim, Jeong Hyun; Cho, Jae Won; Choi, Ji Yeon; Hong, Yong Hee; Lee, Jieun; Kim, Sung Eun; Noh, Ji Yun; Cha, Bong-Soo; Lee, Byung-Wan

Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial

噻唑烷二酮类药物与钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病代谢功能障碍相关脂肪肝的协同作用:一项为期24周的开放标签随机对照试验

Lee, Minyoung; Hong, Sukchul; Cho, Yongin; Rhee, Hyungjin; Yu, Min Heui; Bae, Jaehyun; Lee, Yong-Ho; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong-Soo

Trends in Prevalence of Obesity and Related Cardiometabolic and Renal Complications in Korea: A Nationwide Study 2007 to 2022

韩国肥胖及其相关心血管代谢和肾脏并发症患病率趋势:一项2007年至2022年的全国性研究

Han, Eugene; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong-Soo; Lee, Jangho; Lee, Yong-Ho